As one of the world’s fastest-growing and most dynamic pharmaceutical companies, is passionate in its pursuit of new medicines and treatments to improve health and wellness. The efforts of our research and development initiatives are yielding new and potential treatments for arthritis, cancer, glaucoma and infectious disease. In Canada, the company employs 700 people and invests approximately $35 million in Canadian research and development.